For Info only as there is no public tranche. I also caveat that i know nothing about the biotech industry. Too “genomic-ally Greek” to me…
Clearbridge Health Limited
(“Clearbridge” or the “Company”) is placing out 88m New Shares at $0.28 each for a listing on Catalist. There is no public offering and the Company will commence trading on SGX on 18 Dec 2017. Based on the IPO price, the market cap of the Company is $134.7m You can find the prospectus here
The Company is a healthcare company with a focus on delivery of precision medicine in Asia …🤔… and its vision is to empower clinicians and healthcare professionals to make more reliable and accurate diagnoses, provide insights to disease management and tailor personalised prevention and timely treatment programmes for patients.
It provides lab testing services, owns and operates medical centres and invest strategically in precision medical …